For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering.

Our stock screener has singled out HAEMONETICS CORP/MASS (NYSE:HAE) as an attractive growth opportunity. NYSE:HAE is demonstrating remarkable growth potential while maintaining strong financial indicators, making it a reasonably priced option. We'll explore this further.

Understanding NYSE:HAE's Growth

ChartMill assigns a proprietary Growth Rating to each stock. The score is computed by evaluating various growth aspects, like EPS and revenue growth. We take into account the history as well as the estimated future numbers. NYSE:HAE was assigned a score of 7 for growth:

• The Earnings Per Share has grown by an nice 11.48% over the past year.
• HAE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.74% yearly.
• Looking at the last year, HAE shows a quite strong growth in Revenue. The Revenue has grown by 9.85% in the last year.
• The Earnings Per Share is expected to grow by 21.40% on average over the next years. This is a very strong growth
• The Revenue is expected to grow by 10.74% on average over the next years. This is quite good.
• When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
• The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

Understanding NYSE:HAE's Valuation Score

An integral part of ChartMill's stock analysis is the Valuation Rating, which spans from 0 to 10. This rating evaluates diverse valuation factors, including price to earnings and cash flows, while considering the stock's profitability and growth. NYSE:HAE has received a 6 out of 10:

• 86.63% of the companies in the same industry are more expensive than HAE, based on the Price/Earnings ratio.
• When comparing the Price/Earnings ratio of HAE to the average of the S&P500 Index (28.65), we can say HAE is valued slightly cheaper.
• Based on the Price/Forward Earnings ratio, HAE is valued cheaply inside the industry as 88.77% of the companies are valued more expensively.
• Compared to an average S&P500 Price/Forward Earnings ratio of 23.56, HAE is valued a bit cheaper.
• Based on the Enterprise Value to EBITDA ratio, HAE is valued cheaply inside the industry as 84.49% of the companies are valued more expensively.
• Based on the Price/Free Cash Flow ratio, HAE is valued a bit cheaper than 68.98% of the companies in the same industry.
• HAE has an outstanding profitability rating, which may justify a higher PE ratio.
• HAE's earnings are expected to grow with 16.79% in the coming years. This may justify a more expensive valuation.

Deciphering NYSE:HAE's Health Rating

ChartMill utilizes a Health Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of liquidity and solvency ratios, both in absolute terms and in comparison to industry peers. NYSE:HAE has earned a 5 out of 10:

• HAE has a Altman-Z score of 2.90. This is in the better half of the industry: HAE outperforms 65.78% of its industry peers.
• HAE has a better Debt to FCF ratio (39.37) than 68.45% of its industry peers.
• A Current Ratio of 3.49 indicates that HAE has no problem at all paying its short term obligations.
• HAE has a Quick Ratio of 2.09. This indicates that HAE is financially healthy and has no problem in meeting its short term obligations.

Profitability Examination for NYSE:HAE

ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NYSE:HAE, the assigned 9 is noteworthy for profitability:

• The Return On Assets of HAE (4.90%) is better than 83.96% of its industry peers.
• HAE has a better Return On Equity (14.09%) than 89.30% of its industry peers.
• HAE's Return On Invested Capital of 7.59% is amongst the best of the industry. HAE outperforms 86.63% of its industry peers.
• The 3 year average ROIC (7.51%) for HAE is below the current ROIC(7.59%), indicating increased profibility in the last year.
• Looking at the Profit Margin, with a value of 9.10%, HAE belongs to the top of the industry, outperforming 83.42% of the companies in the same industry.
• In the last couple of years the Profit Margin of HAE has grown nicely.
• Looking at the Operating Margin, with a value of 15.80%, HAE belongs to the top of the industry, outperforming 86.63% of the companies in the same industry.
• In the last couple of years the Operating Margin of HAE has grown nicely.
• In the last couple of years the Gross Margin of HAE has grown nicely.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

Our latest full fundamental report of HAE contains the most current fundamental analsysis.

Disclaimer

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.